Position in ADMA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$6,193,800
-$473,600 QoQ
Shares Held
740,000
0.0% QoQ
Ownership
0.330%
of shares outstanding
% of Portfolio
4.71%
of 13F equity value
Holder Rank
#44
of 323 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Derivatives in ADMA
reported options exposure · as of Jun 30, 2026CallValue
$5,440,500
CallShares
650,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stonepine Capital Management, LLC holds $108,574,607 across 61 Biotechnology names. ADMA ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VSTM |
Verastem, Inc.
|
3,349,627 | $12,795,575 | |
| 2 | TENX |
Tenax Therapeutics, Inc.
|
660,000 | $9,603,000 | |
| 3 | NKTR |
Nektar Therapeutics
|
120,654 | $8,422,855 | |
| 4 | ADMA |
Adma Biologics, Inc.
This page
|
740,000 | $6,193,800 | |
| 5 | CAMP |
Camp4 Therapeutics Corp
|
1,389,622 | $6,072,648 | |
| 6 | ELOX |
Eloxx Pharmaceuticals, Inc.
|
397,160 | $5,512,580 | |
| 7 | KZIA |
Kazia Therapeutics Ltd
|
345,179 | $4,860,120 | |
| 8 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
425,000 | $3,986,500 |
All Filings in ADMA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,193,800 | 740,000 | Shares | Sole | 2026-08-17 | |
| 2026-06-30 | $5,440,500 | 650,000 | Call | Sole | 2026-08-17 | |
| 2026-03-31 | $10,361,500 | 1,150,000 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $6,667,400 | 740,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,497,600 | 740,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,833,740 | 739,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $13,657,500 | 750,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $24,300 | 810,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,283,698 | 1,241,032 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,381,300 | 1,870,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,906,600 | 1,870,000 | Shares | Sole | 2024-08-21 | |
| 2024-03-31 | $22,617,421 | 3,426,882 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $41,686,228 | 9,222,617 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $32,593,304 | 9,104,275 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $32,447,354 | 8,793,321 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $25,360,193 | 7,661,690 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,927,200 | 6,940,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,150,000 | 5,000,000 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $13,860,000 | 7,000,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $13,051,208 | 7,131,808 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,975,323 | 9,911,577 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||